KEGG   PATHWAY: mfot04936
Entry
mfot04936                   Pathway                                
Name
Alcoholic liver disease - Microtus fortis (reed vole)
Description
Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
mfot04936  Alcoholic liver disease
mfot04936

Organism
Microtus fortis (reed vole) [GN:mfot]
Gene
126509825  complement C1q subcomponent subunit A [KO:K03986]
126509872  complement C1q subcomponent subunit B [KO:K03987]
126509794  complement C1q subcomponent subunit C [KO:K03988]
126495378  complement C2 isoform X1 [KO:K01332] [EC:3.4.21.43]
126490398  complement C3 isoform X1 [KO:K03990]
126514863  C3a anaphylatoxin chemotactic receptor [KO:K04009]
126513419  complement C5 [KO:K03994]
126493341  C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
126506989  lipopolysaccharide-binding protein [KO:K05399]
126493390  monocyte differentiation antigen CD14 [KO:K04391]
126501405  lymphocyte antigen 96 isoform X1 [KO:K05400]
126507954  toll-like receptor 4 [KO:K10160]
126487329  toll/interleukin-1 receptor domain-containing adapter protein isoform X1 [KO:K05403]
126501081  myeloid differentiation primary response protein MyD88 [KO:K04729]
126496436  myeloid differentiation primary response protein MyD88-like [KO:K04729]
126492812  interleukin-1 receptor-associated kinase 4 isoform X1 [KO:K04733] [EC:2.7.11.1]
126490221  interleukin-1 receptor-associated kinase 1 isoform X1 [KO:K04730] [EC:2.7.11.1]
126504640  TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
126515732  TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform X1 [KO:K04403]
126513299  TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
126503643  mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
126504083  inhibitor of nuclear factor kappa-B kinase subunit alpha [KO:K04467] [EC:2.7.11.10]
126504411  inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
126490256  NF-kappa-B essential modulator isoform X1 [KO:K07210]
126499590  NF-kappa-B inhibitor alpha [KO:K04734]
126498562  transcription factor p65 isoform X1 [KO:K04735]
126502367  nuclear factor NF-kappa-B p105 subunit [KO:K02580]
126494877  tumor necrosis factor [KO:K03156]
126496850  interleukin-1 beta [KO:K04519]
126491159  interleukin-6 [KO:K05405]
126504946  interleukin-12 subunit alpha [KO:K05406]
126499523  interleukin-12 subunit beta [KO:K05425]
126490323  TIR domain-containing adapter molecule 1 [KO:K05842]
126509072  TNF receptor-associated factor 3 isoform X1 [KO:K03174]
126504983  inhibitor of nuclear factor kappa-B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
126515694  serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
126488203  interferon regulatory factor 3 isoform X1 [KO:K05411]
126510709  interferon alpha-12-like [KO:K05414]
126510710  interferon alpha-12-like [KO:K05414]
126510711  interferon alpha-12-like [KO:K05414]
126510712  interferon alpha-12-like [KO:K05414]
126510718  interferon alpha-12-like [KO:K05414]
126510725  interferon alpha-1-like [KO:K05414]
126510729  interferon alpha-1-like [KO:K05414]
126510739  interferon alpha-12-like [KO:K05414]
126510740  interferon alpha-12-like [KO:K05414]
126510741  interferon beta [KO:K05415]
126489678  interleukin-17A [KO:K05489]
126514877  interleukin-17 receptor A [KO:K05164]
126505468  interleukin-17 receptor C isoform X1 [KO:K05166]
126506338  C-X-C motif chemokine 3-like [KO:K05505]
126506591  C-X-C motif chemokine 2-like [KO:K05505]
126506592  growth-regulated alpha protein [KO:K05505]
126511310  tumor necrosis factor ligand superfamily member 6 [KO:K04389]
126511231  tumor necrosis factor receptor superfamily member 6 [KO:K04390]
126505976  LOW QUALITY PROTEIN: FAS-associated death domain protein-like [KO:K02373]
126498470  FAS-associated death domain protein [KO:K02373]
126514827  tumor necrosis factor receptor superfamily member 1A [KO:K03158]
126502907  tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
126511842  caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
126495899  caspase-3-like isoform X1 [KO:K02187] [EC:3.4.22.56]
126504830  caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
126501520  receptor-interacting serine/threonine-protein kinase 1 [KO:K02861] [EC:2.7.11.1]
126492099  TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 isoform X1 [KO:K12793]
126514707  sterol regulatory element-binding protein 1 isoform X1 [KO:K07197]
126500521  fatty acid synthase [KO:K00665] [EC:2.3.1.85]
126487013  acetyl-CoA carboxylase 1 isoform X1 [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
126503782  acyl-CoA desaturase 3 isoform X1 [KO:K00507] [EC:1.14.19.1]
126503792  acyl-CoA desaturase 1 isoform X1 [KO:K00507] [EC:1.14.19.1]
126503803  stearoyl-CoA desaturase 2 isoform X1 [KO:K00507] [EC:1.14.19.1]
126507066  phosphatidate phosphatase LPIN3 isoform X1 [KO:K15728] [EC:3.1.3.4]
126501257  phosphatidate phosphatase LPIN1 isoform X1 [KO:K15728] [EC:3.1.3.4]
126516050  phosphatidate phosphatase LPIN2 isoform X1 [KO:K15728] [EC:3.1.3.4]
126500845  NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
126504204  transformer-2 protein homolog beta isoform X1 [KO:K12897]
126491138  transformer-2 protein homolog alpha isoform X1 [KO:K12897]
126512286  adiponectin [KO:K07296]
126505442  adiponectin receptor protein 2 [KO:K07297]
126488530  LOW QUALITY PROTEIN: adiponectin receptor protein 1-like [KO:K07297]
126504976  adiponectin receptor protein 1 [KO:K07297]
126504174  calcium/calmodulin-dependent protein kinase kinase 2 isoform X1 [KO:K07359] [EC:2.7.11.17]
126499666  5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1 [KO:K07198] [EC:2.7.11.31]
126498016  5'-AMP-activated protein kinase catalytic subunit alpha-2 isoform X1 [KO:K07198] [EC:2.7.11.31]
126490093  5'-AMP-activated protein kinase subunit beta-2 isoform X1 [KO:K07199]
126511686  5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
126492941  5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
126493763  5'-AMP-activated protein kinase subunit gamma-1 [KO:K07200]
126489412  5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200]
126499179  forkhead box protein O1 [KO:K07201]
126487590  forkhead box protein O3 [KO:K09408]
126506240  peroxisome proliferator-activated receptor gamma coactivator 1-alpha [KO:K07202]
126491970  peroxisome proliferator-activated receptor alpha [KO:K07294]
126498390  carnitine O-palmitoyltransferase 1, liver isoform [KO:K08765] [EC:2.3.1.21]
126513897  very long-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K09479] [EC:1.3.8.9]
126506150  medium-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K00249] [EC:1.3.8.7]
126500548  peroxisomal acyl-coenzyme A oxidase 1 isoform X1 [KO:K00232] [EC:1.3.3.6]
126500818  peroxisomal acyl-coenzyme A oxidase 3 [KO:K00232] [EC:1.3.3.6]
126491045  fatty acid-binding protein, liver [KO:K08750]
126488345  alcohol dehydrogenase 1 isoform X1 [KO:K13951] [EC:1.1.1.1]
126496003  alcohol dehydrogenase 1-like [KO:K13951] [EC:1.1.1.1]
126491271  alcohol dehydrogenase 1C isoform X1 [KO:K13951] [EC:1.1.1.1]
126491273  all-trans-retinol dehydrogenase [NAD(+)] ADH7 [KO:K13951] [EC:1.1.1.1]
126488344  all-trans-retinol dehydrogenase [NAD(+)] ADH4 isoform X1 [KO:K13980] [EC:1.1.1.1]
126512462  alcohol dehydrogenase class-3 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
126488347  alcohol dehydrogenase class-3-like [KO:K00121] [EC:1.1.1.284 1.1.1.1]
126488339  alcohol dehydrogenase 6 isoform X1 [KO:K13952] [EC:1.1.1.1]
126514623  LOW QUALITY PROTEIN: aldehyde dehydrogenase family 3 member A2 [KO:K00128] [EC:1.2.1.3]
126509875  aldehyde dehydrogenase X, mitochondrial [KO:K00128] [EC:1.2.1.3]
126511638  aldehyde dehydrogenase, mitochondrial [KO:K00128] [EC:1.2.1.3]
126487857  alpha-aminoadipic semialdehyde dehydrogenase [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
126511267  4-trimethylaminobutyraldehyde dehydrogenase [KO:K00149] [EC:1.2.1.47 1.2.1.3]
126498260  cytochrome P450 2E1 [KO:K07415] [EC:1.14.14.-]
126487966  acetyl-CoA carboxylase 2 isoform X1 [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
126502842  malonyl-CoA decarboxylase, mitochondrial [KO:K01578] [EC:4.1.1.9]
126493333  carnitine O-palmitoyltransferase 1, muscle isoform [KO:K19523] [EC:2.3.1.21]
126488168  carnitine O-palmitoyltransferase 1, brain isoform isoform X1 [KO:K19524] [EC:2.3.1.21]
126491513  NADPH oxidase 4 isoform X1 [KO:K21423] [EC:1.6.3.-]
126492538  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
126502126  RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
126509082  RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
126505874  glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
126501053  catenin beta-1 [KO:K02105]
126510979  transcription factor 7 isoform X1 [KO:K02620]
126493279  transcription factor 7-like 1 isoform X1 [KO:K04490]
126505923  transcription factor 7-like 2 isoform X1 [KO:K04491]
126509833  lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
126498427  G1/S-specific cyclin-D1 [KO:K04503]
126511959  mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
126513961  dual specificity mitogen-activated protein kinase kinase 4 isoform X1 [KO:K04430] [EC:2.7.12.2]
126491615  dual specificity mitogen-activated protein kinase kinase 7 isoform X1 [KO:K04431] [EC:2.7.12.2]
126500615  mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
126509741  mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
126511413  mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
126514653  dual specificity mitogen-activated protein kinase kinase 3 isoform X1 [KO:K04432] [EC:2.7.12.2]
126500469  dual specificity mitogen-activated protein kinase kinase 6 isoform X1 [KO:K04433] [EC:2.7.12.2]
126492719  mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
126492755  mitogen-activated protein kinase 11 isoform X1 [KO:K04441] [EC:2.7.11.24]
126501977  mitogen-activated protein kinase 13 isoform X1 [KO:K04441] [EC:2.7.11.24]
126502008  mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
126510438  mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
Compound
C00003  NAD+
C00005  NADPH
C00006  NADP+
C00024  Acetyl-CoA
C00033  Acetate
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00084  Acetaldehyde
C00469  Ethanol
C22381  Reactive oxygen species
Reference
  Authors
Louvet A, Mathurin P
  Title
Alcoholic liver disease: mechanisms of injury and targeted treatment.
  Journal
Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
DOI:10.1038/nrgastro.2015.35
Reference
  Authors
Gao B, Bataller R
  Title
Alcoholic liver disease: pathogenesis and new therapeutic targets.
  Journal
Gastroenterology 141:1572-85 (2011)
DOI:10.1053/j.gastro.2011.09.002
Reference
  Authors
Magdaleno F, Blajszczak CC, Nieto N
  Title
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  Journal
Biomolecules 7:E9 (2017)
DOI:10.3390/biom7010009
Reference
  Authors
Lucey MR, Mathurin P, Morgan TR
  Title
Alcoholic hepatitis.
  Journal
N Engl J Med 360:2758-69 (2009)
DOI:10.1056/NEJMra0805786
Reference
  Authors
Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  Title
Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  Journal
Gastroenterology 150:1756-68 (2016)
DOI:10.1053/j.gastro.2016.02.035
Reference
  Authors
Fujii H, Kawada N
  Title
Fibrogenesis in alcoholic liver disease.
  Journal
World J Gastroenterol 20:8048-54 (2014)
DOI:10.3748/wjg.v20.i25.8048
Reference
  Authors
Kim MS, Ong M, Qu X
  Title
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  Journal
World J Gastroenterol 22:8-23 (2016)
DOI:10.3748/wjg.v22.i1.8
Reference
  Authors
You M, Crabb DW
  Title
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  Journal
Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
DOI:10.1152/ajpgi.00056.2004
Reference
  Authors
Nagy LE
  Title
The Role of Innate Immunity in Alcoholic Liver Disease.
  Journal
Alcohol Res 37:237-50 (2015)
Reference
  Authors
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  Title
Innate immunity in alcoholic liver disease.
  Journal
Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
DOI:10.1152/ajpgi.00537.2010
Reference
  Authors
Wang HJ, Gao B, Zakhari S, Nagy LE
  Title
Inflammation in alcoholic liver disease.
  Journal
Annu Rev Nutr 32:343-68 (2012)
DOI:10.1146/annurev-nutr-072610-145138
Reference
  Authors
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  Title
Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  Journal
Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
DOI:10.1152/ajpgi.00334.2017
Reference
  Authors
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  Title
The effect of inflammatory cytokines in alcoholic liver disease.
  Journal
Mediators Inflamm 2013:495156 (2013)
DOI:10.1155/2013/495156
Reference
  Authors
Szabo G, Bala S
  Title
Alcoholic liver disease and the gut-liver axis.
  Journal
World J Gastroenterol 16:1321-9 (2010)
DOI:10.3748/wjg.v16.i11.1321
Reference
  Authors
Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  Title
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  Journal
Int J Mol Med 40:263-270 (2017)
DOI:10.3892/ijmm.2017.3015
Reference
  Authors
Roh YS, Seki E
  Title
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  Journal
J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
DOI:10.1111/jgh.12019
Reference
  Authors
Rogers CQ, Ajmo JM, You M
  Title
Adiponectin and alcoholic fatty liver disease.
  Journal
IUBMB Life 60:790-7 (2008)
DOI:10.1002/iub.124
Reference
  Authors
You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  Title
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  Journal
Curr Mol Pharmacol 10:226-236 (2017)
DOI:10.2174/1874467208666150817112109
Reference
  Authors
You M, Jogasuria A, Taylor C, Wu J
  Title
Sirtuin 1 signaling and alcoholic fatty liver disease.
  Journal
Hepatobiliary Surg Nutr 4:88-100 (2015)
DOI:10.3978/j.issn.2304-3881.2014.12.06
Reference
  Authors
Ren R, Wang Z, Wu M, Wang H
  Title
Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  Journal
Int J Biol Sci 16:3174-3183 (2020)
DOI:10.7150/ijbs.49535
Reference
  Authors
Purohit V, Gao B, Song BJ
  Title
Molecular mechanisms of alcoholic fatty liver.
  Journal
Alcohol Clin Exp Res 33:191-205 (2009)
DOI:10.1111/j.1530-0277.2008.00827.x
Reference
  Authors
Hyun J, Han J, Lee C, Yoon M, Jung Y
  Title
Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  Journal
Int J Mol Sci 22:5717 (2021)
DOI:10.3390/ijms22115717
Reference
  Authors
Combs TP, Marliss EB
  Title
Adiponectin signaling in the liver.
  Journal
Rev Endocr Metab Disord 15:137-47 (2014)
DOI:10.1007/s11154-013-9280-6
Reference
  Authors
Ceni E, Mello T, Galli A
  Title
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  Journal
World J Gastroenterol 20:17756-72 (2014)
DOI:10.3748/wjg.v20.i47.17756
Reference
  Authors
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  Title
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  Journal
Int J Mol Sci 20:E2712 (2019)
DOI:10.3390/ijms20112712
Reference
  Authors
Ohashi K, Pimienta M, Seki E
  Title
Alcoholic liver disease: A current molecular and clinical perspective.
  Journal
Liver Res 2:161-172 (2018)
DOI:10.1016/j.livres.2018.11.002
Reference
  Authors
You M, Arteel GE
  Title
Effect of ethanol on lipid metabolism.
  Journal
J Hepatol 70:237-248 (2019)
DOI:10.1016/j.jhep.2018.10.037
Reference
  Authors
Bi L, Jiang Z, Zhou J
  Title
The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  Journal
Alcohol Alcohol 50:146-51 (2015)
DOI:10.1093/alcalc/agu102
Reference
  Authors
Ali H, Assiri MA, Shearn CT, Fritz KS
  Title
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  Journal
Curr Opin Toxicol 13:110-117 (2019)
DOI:10.1016/j.cotox.2018.10.003
Reference
  Authors
Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  Title
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  Journal
Gastroenterology 146:801-11 (2014)
DOI:10.1053/j.gastro.2013.11.008
Reference
  Authors
Stickel F, Hampe J
  Title
Genetic determinants of alcoholic liver disease.
  Journal
Gut 61:150-9 (2012)
DOI:10.1136/gutjnl-2011-301239
Reference
  Authors
Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  Title
NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  Journal
Int J Mol Med 41:2306-2316 (2018)
DOI:10.3892/ijmm.2018.3390
Related
pathway
mfot00061  Fatty acid biosynthesis
mfot00071  Fatty acid degradation
mfot01040  Biosynthesis of unsaturated fatty acids
mfot03040  Spliceosome
mfot04010  MAPK signaling pathway
mfot04064  NF-kappa B signaling pathway
mfot04152  AMPK signaling pathway
mfot04210  Apoptosis
mfot04310  Wnt signaling pathway
mfot04610  Complement and coagulation cascades
mfot04620  Toll-like receptor signaling pathway
mfot04657  IL-17 signaling pathway
mfot04668  TNF signaling pathway
mfot04920  Adipocytokine signaling pathway
mfot05034  Alcoholism
mfot05225  Hepatocellular carcinoma
KO pathway
ko04936   
LinkDB

DBGET integrated database retrieval system